Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 2806365)

Published in Respir Res on December 29, 2009

Authors

Chen Wang1, Zhenguo Zhai, Yuanhua Yang, Yadong Yuan, Zhaozhong Cheng, Lirong Liang, Huaping Dai, Kewu Huang, Weixuan Lu, Zhonghe Zhang, Xiansheng Cheng, Ying H Shen, China Venous Thromboembolism Study Group

Author Affiliations

1: Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, PR China. cyh-birm@263.net

Associated clinical trials:

PEITHO Pulmonary Embolism Thrombolysis Study (PEITHO) | NCT00639743

12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China (UKPTEC) | NCT00799968

NCT 00799968

Articles cited by this

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med (2002) 8.28

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J (1999) 2.13

The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest (2004) 2.05

Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol (1992) 1.85

New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am J Roentgenol (2001) 1.66

Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology (2005) 1.54

Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest (1997) 1.27

Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet (1988) 1.24

Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol (1998) 1.15

Acute massive pulmonary embolism. Clinical and haemodynamic findings in 23 patients studied by cardiac catheterization and pulmonary arteriography. Br Heart J (1970) 1.02

Comparison of lung scanning and pulmonary angiography in the detection and follow-up of pulmonary embolism: the Urokinase-Pulmonary Embolism Trial experience. Prog Cardiovasc Dis (1975) 0.99

Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism. Eur J Nucl Med (1990) 0.95

Right ventricular dysfunction secondary to acute massive pulmonary embolism detected by helical computed tomography pulmonary angiography. Clin Imaging (2005) 0.91

Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism. Am J Cardiol (1992) 0.89

Value of transthoracic echocardiography combined with cardiac troponin I in risk stratification in acute pulmonary thromboembolism. Chin Med J (Engl) (2007) 0.89

The urokinase-pulmonary embolism trial. Circulation (1969) 0.88

[Multicenter clinical trial on the efficacy of thrombolytic therapy with urokinase and/or anticoagulant with low molecular weight heparin in acute pulmonary embolism]. Zhonghua Nei Ke Za Zhi (2002) 0.86

Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vasc Interv Radiol (1997) 0.84

Acute pulmonary embolism advances in treatment. J Assoc Physicians India (2008) 0.82

The phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative study. Thromb Diath Haemorrh (1975) 0.79

The UKEP study: multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism. The UKEP Study Research Group. Eur Heart J (1987) 0.79

Pulmonary embolism and the urokinase pulmonary embolism trial. J Med Assoc Ga (1970) 0.78

Controversies of different regimens of thrombolytic therapy in acute pulmonary embolism. Semin Thromb Hemost (1987) 0.78

Urokinase pulmonary embolism trial. JAMA (1971) 0.78

[Experimental study of the thrombolytic effects in a canine model of pulmonary thromboembolism induced by autologous radioactive blood clots]. Zhonghua Jie He He Hu Xi Za Zhi (2004) 0.77

Thrombolytic therapy in patients with submassive pulmonary embolism. N Engl J Med (2003) 0.77

Selection of patients with acute pulmonary embolism for thrombolytic therapy. Thrombolysis in pulmonary embolism (TIPE) patient survey. The TIPE Investigators. Chest (1989) 0.77

Articles by these authors

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med (2009) 6.45

Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest (2009) 3.23

Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med (2012) 2.43

A prospective, multicenter survey on causes of chronic cough in China. Chest (2013) 2.38

ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections. Ann Thorac Surg (2012) 2.18

Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci U S A (2005) 1.85

A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg (2006) 1.57

TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway. Arterioscler Thromb Vasc Biol (2007) 1.55

Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone. Chest (2003) 1.50

Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes (2006) 1.46

The values of thin sections and three-dimensional reconstruction in the sellar region. World Neurosurg (2011) 1.40

Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol (2009) 1.40

Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes (2009) 1.39

Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation (2006) 1.30

Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem Biophys Res Commun (2009) 1.23

Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun (2010) 1.12

Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis. Arch Med Res (2008) 1.10

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice. Respir Res (2010) 1.07

Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J Biol Chem (2005) 1.06

Global expression profiles from C57BL/6J and DBA/2J mouse lungs to determine aging-related genes. Physiol Genomics (2007) 1.03

Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events. Heart (2011) 1.03

Pulmonary embolism incidence and fatality trends in chinese hospitals from 1997 to 2008: a multicenter registration study. PLoS One (2011) 1.02

Genotype-dependent expression of endothelial nitric oxide synthase (eNOS) and its regulatory proteins in cultured endothelial cells. DNA Cell Biol (2005) 0.99

A new Tn1546 type of VanB phenotype-vanA genotype vancomycin-resistant Enterococcus faecium isolates in mainland China. Diagn Microbiol Infect Dis (2009) 0.97

Effect of nuclear actin on endothelial nitric oxide synthase expression. Arterioscler Thromb Vasc Biol (2005) 0.97

Molecular mechanisms of thoracic aortic dissection. J Surg Res (2013) 0.96

Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia. Immunobiology (2012) 0.96

Decreased expression of fibulin-5 correlates with reduced elastin in thoracic aortic dissection. Surgery (2005) 0.95

Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis. Circ J (2011) 0.94

Human prolyl-4-hydroxylase alpha(I) transcription is mediated by upstream stimulatory factors. J Biol Chem (2006) 0.94

Prevalence and associations of VTE in patients with newly diagnosed lung cancer. Chest (2014) 0.94

Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene. J Biol Chem (2008) 0.93

Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell (2008) 0.93

Thoracic aortic dissection: are matrix metalloproteinases involved? Vascular (2009) 0.93

Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology (2008) 0.92

PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity. Biochem Biophys Res Commun (2010) 0.91

Attenuation of antigen-induced airway hyperresponsiveness and inflammation in CXCR3 knockout mice. Respir Res (2011) 0.89

Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase. Exp Biol Med (Maywood) (2013) 0.88

Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers. Respirology (2014) 0.88

Value of right ventricular dysfunction for prognosis in pulmonary embolism. Int J Cardiol (2007) 0.87

Spatial-temporal atlas of human fetal brain development during the early second trimester. Neuroimage (2013) 0.87

Rapamycin inhibits transforming growth factor β1-induced fibrogenesis in primary human lung fibroblasts. Yonsei Med J (2013) 0.86

Mechanisms for human cytomegalovirus-induced cytoplasmic p53 sequestration in endothelial cells. J Cell Sci (2006) 0.86

[Multicenter clinical trial on the efficacy of thrombolytic therapy with urokinase and/or anticoagulant with low molecular weight heparin in acute pulmonary embolism]. Zhonghua Nei Ke Za Zhi (2002) 0.86

Age-induced augmentation of p38 MAPK phosphorylation in mouse lung. Exp Gerontol (2011) 0.85

Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. Biochem Biophys Res Commun (2005) 0.84

Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4. Biochem Biophys Res Commun (2010) 0.84

Factors associated with compliance to lipid-lowering treatment in China. Eur J Prev Cardiol (2012) 0.84

Meta-analysis of genetic programs between idiopathic pulmonary fibrosis and sarcoidosis. PLoS One (2013) 0.84

Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy. Lipids Health Dis (2012) 0.83

Beneficial effects of inhaled NO on apoptotic pneumocytes in pulmonary thromboembolism model. Theor Biol Med Model (2014) 0.83

Computed tomographic pulmonary angiography in the assessment of severity of chronic thromboembolic pulmonary hypertension and right ventricular dysfunction. Eur J Radiol (2010) 0.83

HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis-- involvement of ERK pathway. FEBS Lett (2006) 0.82

The language of medically unexplained dyspnea. Chest (2008) 0.82

Extrinsic allergic alveolitis: inhibitory effects of pentoxifylline on cytokine production by alveolar macrophages. Ann Allergy Asthma Immunol (2004) 0.82

Evaluation of asthma control and patient's perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China. J Asthma (2013) 0.81

Cardiovascular parameters of computed tomographic pulmonary angiography to assess pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol (2011) 0.81

Inflammatory response and pneumocyte apoptosis during lung ischemia-reperfusion injury in an experimental pulmonary thromboembolism model. J Thromb Thrombolysis (2015) 0.81

Role of NonO-histone interaction in TNFalpha-suppressed prolyl-4-hydroxylase alpha1. Biochim Biophys Acta (2008) 0.81

Altered Th1/Th2 commitment contributes to lung senescence in CXCR3-deficient mice. Exp Gerontol (2013) 0.80

Development of the subcortical brain structures in the second trimester: assessment with 7.0-T MRI. Neuroradiology (2012) 0.80

[Significance of the changes of platelet activation and fibrinolytic activity in patients with obstructive sleep apnea-hypopnea syndrome]. Zhonghua Jie He He Hu Xi Za Zhi (2002) 0.80

Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism. J Thromb Thrombolysis (2007) 0.80

Sequential non-invasive mechanical ventilation following short-term invasive mechanical ventilation in COPD induced hypercapnic respiratory failure. Chin Med J (Engl) (2003) 0.80

[Risk factors and prognosis of lung cancer combined with pulmonary embolism]. Zhongguo Fei Ai Za Zhi (2011) 0.79

PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1. Eur J Pharmacol (2013) 0.79

Relationship between -592A/C polymorphism of interleukin-10 (IL-10) gene and risk of early carotid atherosclerosis. Int J Cardiol (2008) 0.79

Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue. Int J Mol Med (2013) 0.79

Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumonia. Respir Med (2010) 0.79

Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as first-line therapy for advanced gastric cancer. J Chemother (2013) 0.79

Notch signaling in descending thoracic aortic aneurysm and dissection. PLoS One (2012) 0.78

Chronic bronchitis leads to accelerated hyperinflation in COPD patients during exercise. Respirology (2015) 0.78

[Clinical analysis of 43 patients with eosinophilic granulomatosis with polyangiitis]. Zhonghua Yi Xue Za Zhi (2016) 0.77

JNK-ATF-2 inhibits thrombomodulin (TM) expression by recruiting histone deacetylase4 (HDAC4) and forming a transcriptional repression complex in the TM promoter. FEBS Lett (2010) 0.77

Development of the human fetal cerebellum in the second trimester: a post mortem magnetic resonance imaging evaluation. J Anat (2011) 0.77

Free fatty acids inhibit TM-EPCR expression through JNK pathway: an implication for the development of the prothrombotic state in metabolic syndrome. J Thromb Thrombolysis (2012) 0.77

A longitudinal study of carotid plaque and risk of ischemic cardiovascular disease in the Chinese population. J Am Soc Echocardiogr (2011) 0.77

Association of SERPINE2 gene with the risk of chronic obstructive pulmonary disease and spirometric phenotypes in northern Han Chinese population. Mol Biol Rep (2011) 0.77

Mitochondria depletion abolishes agonist-induced Ca2+ plateau in airway smooth muscle cells: potential role of H2O2. Am J Physiol Lung Cell Mol Physiol (2009) 0.77

Microarray expression profile of circular RNAs in chronic thromboembolic pulmonary hypertension. Medicine (Baltimore) (2017) 0.76